Three infants in three states have been hospitalized in a new botulism outbreak linked to recalled Nara Organics Whole Milk Organic Powdered Infant Formula, federal health officials said.
The cases were reported in California, Pennsylvania, and Washington. The illness onsets stretched from April into late May, turning what looked like separate medical emergencies into a multistate investigation now being watched closely by parents, pediatricians, retailers, and federal regulators.
The recalled formula was sold through Target retail stores, Target.com, and Nara.com. Health officials have urged parents and caregivers not to feed infants the recalled product while the investigation continues.
A Rare Illness with Serious Consequences

Infant botulism is rare, but it is not a small medical event. It happens when a baby swallows spores of Clostridium botulinum, bacteria that can grow inside the infant’s intestines and produce a dangerous toxin.
The illness can begin quietly. A baby may struggle to feed, appear weak, have constipation, lose head control, or show difficulty sucking and swallowing. In more serious cases, the weakness can progress into limpness, breathing problems, and respiratory failure.
That slow progression is part of what makes the outbreak so alarming. Symptoms may not appear immediately after a baby consumes a contaminated product. Parents may only notice something is wrong days or even weeks later, when feeding changes, crying weakens, or the baby seems unusually tired.
What Officials Know So Far
The outbreak currently includes three infants. All three were hospitalized and are receiving treatment. Federal officials said the infants consumed Nara Organics Whole Milk Organic Powdered Infant Formula before becoming ill. The FDA and CDC are working with state health departments and the Infant Botulism Treatment and Prevention Program as the investigation continues.
The FDA said officials in two states have collected leftover formula for testing. Those results are still pending, which means investigators have not yet publicly identified a confirmed contamination source.
Nara Organics said it issued the recall after the FDA provided epidemiological information about the three cases. The company also said no Nara formula had tested positive for C. botulinum at the time of its recall notice, but it chose to recall all U.S. product as a precaution.
The Recall Covers Nara Formula in the U.S.

The recall applies to Nara Organics Whole Milk Organic Infant Formula currently available in the United States. The product was distributed nationally through Target stores, Target.com, and Nara.com.
For many parents, the Target connection is what makes this story feel close to home. This was not
